11h
Laredo Morning Times on MSNLaredo's real estate market expands with nearshoring but faces economic challengesLaredo's real estate market is expected to grow through 2025, driven by nearshoring and its status as a top land commercial ...
The Patrick J. Ottensmeyer International Rail Bridge officially opened this month, strengthening trade between Mexico, the United States and Canada. The project, a $100 million investment, integrates ...
Competition from Him & Hers Health seems to be weighing on Novo Nordisk's stock ... may be helpful in getting people to drink less. Forty-eight patients studied over nine weeks, reports JAMA ...
2d
Laredo Morning Times on MSNMexican Consulate in Laredo offers community leader certification courseA course designed to strengthen the capacity of the Consulate General of Mexico in Laredo and enhance its connection with communities in the consular district, particularly those farther from the ...
As our truck ground to a halt, we spotted a group of people-smugglers 200 metres away, fanning thick plumes of smoke from a fire they had built to disguise migrants crossing into New Mexico.
Neighbors in South Laredo were left in shock Wednesday morning, February 12, after federal agents allegedly detained two ...
A migrant prison gang member who has entered the U.S. illegally 10 times and is wanted for murder in Mexico has been deported, Immigration and Customs Enforcement (ICE) announced on Friday.
The AP, which is considered the gold standard of independent journalism, called Trump's retaliation an "alarming" violation of the First Amendment Kyler Alvord is a news editor at PEOPLE ...
"The acquisition will enable us to reach significantly more people living with serious chronic diseases," he added. Novo Nordisk has previously indicated that the acquisition of the three Catalent ...
For comparison, people treated with placebo experienced an estimated 1.9%, 2.3%, and 2.0% body weight gain, respectively. Novo Nordisk's head of development said he was "very encouraged" by the ...
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results